Streetbeat News

Stock Prices

NAMS

NewAmsterdam Pharma shares are trading lower after the company announced its phase 3 BROOKLYN trial results for Obicetrapib in reducing LDL-C.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 1:07 pm

OIS

Oil Sales shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 1:06 pm

INMB

INmune Bio Inc. (NASDAQ: INMB) presented new Phase 1 study data at the Alzheimer's Association International Conference (AAIC) demonstrating the dose-dependent effect of their drug XPro on synaptic proteins in Alzheimer's patients.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 1:06 pm

BMY

GILD

PFE

Wall Street's most accurate analysts recommend holding three high-yielding health care stocks: Gilead Sciences, Pfizer, and Bristol-Myers Squibb. These stocks offer dividend yields over 3% and have received mixed ratings from top analysts.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 1:04 pm

LADR

Analysts have provided mixed ratings for Ladder Cap (NYSE:LADR) over the past quarter, with a recent average price target of $13.25, up from $11.75. The company has shown strong financial performance with notable revenue growth, high net margins, and effective debt management.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 1:01 pm

CROX

Over the past three months, 9 analysts have evaluated Crocs (NASDAQ:CROX), with opinions ranging from bullish to bearish. The average 12-month price target has increased by 6.19% to $162.0. Analysts have recently adjusted their ratings and price targets, reflecting their views on Crocs' market performance and financial health.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 1:01 pm

HZO

Analysts have provided a range of ratings for MarineMax (NYSE:HZO) over the past three months, with all five analysts currently bullish. The average 12-month price target has increased to $41.8, reflecting a 10.58% rise from the previous average. Analysts have raised their price targets, indicating positive sentiment towards the company's future performance.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 1:00 pm

MHK

Mohawk Industries (NYSE:MHK) reported mixed Q2 results, with earnings per share beating estimates but sales missing expectations. The company saw a 19.5% increase in share price following the results. Analysts have raised their price targets, with Baird, Truist Securities, and B of A Securities all making upward revisions.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:59 pm

MCD

McDonald's $5 meal deals have exceeded sales expectations, positively shifting customer sentiment towards the brand's value and affordability. The company anticipates that economic pressures will continue to affect customers for the next several quarters in a competitive market.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:54 pm

IPA

ImmunoPrecise Antibodies reported Q4 sales of C$6.459 million, missing the estimate of C$6.530 million.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:53 pm